hearing loss

— Update from Lancet Commission incorporates vision loss, high LDL to risk factors PHILADELPHIA -- The Lancet Commission on dementia prevention, intervention, and care has expanded the list of modifiable risk factors linked to cognitive decline to 14, after new research conducted since its previous report in 2020. Vision loss and elevated low-density lipoprotein (LDL) cholesterol have been added to the commission's risk factor list, which previously included 12. This revised 57-page

Gene therapy applied to both ears in children with DFNB9 shows enhanced outcomes, including improved sound localization and hearing in noisy settings KEY POINTS BOSTON (June 5, 2024) — A breakthrough gene therapy targeting a genetic form of deafness has demonstrated restored hearing function in five children treated in both ears. These children exhibited significant improvements in speech recognition and could now discern the location of sounds. This bilateral gene therapy—administered to the